Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company LG Life Sciences Ltd.
DescriptionPurinergic receptor P2Y G protein-coupled 12 (P2RY12; P2Y12) inhibitor
Molecular Target Purinergic receptor P2Y G protein-coupled 12 (P2RY12) (P2Y12)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAtherosclerosis
Indication DetailsTreat atherothrombosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today